Recent news on Exenatide

Amylin Pharmaceuticals to Present at Bank of America Healthcare ...  -  25 May 2007
PharmaLive.com (press release),Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN(R) (pramlintide acetate) injection and BYETTA(R) (exenatide)

Exenatide Similar to Insulin in Reducing Blood Glucose, but Also ...  -  Apr 26, 2007
DG NewsExenatide was administered as a fixed 10 mcg dose BID, and insulin was titrated regularly and administered QD (insulin glargine) or BID (biphasic insulin

Lizard's spit leads to diabetes drug  -  May 7, 2007
Telegraph.co.uk,Exenatide, which works by stimulating the pancreas to produce more insulin in response to raised blood sugar, was launched in the UK last week under the

Lizard’s poison may be boon for diabetics  -  May 7, 2007
The Herald,This month, a new type 2 diabetes drug, exenatide, based on the chemical from the garish pink and black lizard, Heloderma suspectum, is available in the UK.

Amylin Pharmaceuticals Selects West Chester, Ohio as the Site for ...  -  May 3, 2007
PharmaLive.com (press release),Exenatide LAR is being developed for once-weekly administration. BYETTA is the trade name for Amylin's formulation of exenatide that has been approved by

Diabetes drug comes from poison lizard  -  May 10, 2007
United Press InternationalThe drug, exenatide, was found by scientists to relieve heart disease, kidney failure and blindness in diabetes patients, The (London) Telegraph reported

Lizard lifeline for diabetics  -  May 9, 2007
Persian Journal,Exenatide is the first in a new class of medicines known as incretin mimetics. It works by stimulating the pancreas to produce more insulin in response to

The monster that can help to lick diabetes  -  May 21, 2007
Times Online,Lilly and Amylin have produced an artificial injectable drug, Byetta (exenatide), that is based on the exendin-4 found in the gila’s saliva.

Amylin building $400M facility in West Chester  -  May 3, 2007
San Antonio Business Journal,The company will make a long-acting release formulation of exenatide, a compound in development for the management of Type 2 diabetes, at the facility,

Lizard spit that can control diabetes  -  May 7, 2007
This is London,This quality has been copied and produced synthetically in the injectable drug exenatide, which is being used to treat type 2 diabetes.

Amylin to spend $400 million on Ohio plant  -  May 4, 2007
San Diego Union Tribune,...continues to make progress in the development of the drug it will make there – a long-acting-release version of its drug exenatide, for Type 2 diabetes.

Amylin to add 500 jobs  -  May 2, 2007
Cincinnati Enquirer,...in 2005 to hire 150 to produce the new long-acting release exenatide, now in clinical trials, and expected to be ready for commercial release in 2008.

Insulin therapy for diabetes  -  May 16, 2007
Chennai Online,Another drug called Byetta (exenatide) induces insulin secretion by pancreas in type 2 diabetics whose pancreas is still functioning.

New Type 2 Drugs Januvia and Byetta Offer Big Benefits  -  May 2, 2007
Diabetes Health (press release),For the type 2 diabetic, the most important new drug to come to market is very likely Byetta (exenatide), which is manufactured and marketed by Eli Lilly

Governor, pharmaceutical company announce manufacturing expansion  -  May 2, 2007
Akron Beacon Journal,The company intends to manufacture LAR, Amylin's long-acting release formulation of the diabetes drug exenatide. The drug, currently in clinical development

Exenatide Similar to Insulin in Reducing Blood Glucose, but Also ...  -  26 Apr 2007
DG NewsExenatide was administered as a fixed 10 mcg dose BID, and insulin was titrated regularly and administered QD (insulin glargine) or BID (biphasic insulin

New injectable treatment for type II diabetes  -  26 Apr 2007
Healthcare RepublicLilly has launched Byetta (exenatide) for the treatment of type II diabetes mellitus, in combination with metformin and/or sulphonylureas, in patients who

Exenatide in Combination Therapy: Small Study, Big Market, and ...  -  Apr 2, 2007
Annals of Internal MedicineIn a randomized trial in this issue (5), we learn about use of a GLP mimetic—exenatide—in combination with a TZD. The study was designed, conducted,

The Effect of Adding Exenatide to a Thiazolidinedione in ...  -  Apr 2, 2007
Annals of Internal MedicineBackground: Exenatide therapy is effective in combination with metformin or sulfonylureas for treating type 2 diabetes. Thiazolidinediones (TZDs) also are

Exenatide Therapy for Type 2 Diabetes  -  Apr 2, 2007
Annals of Internal MedicineThe summary below is from the full report titled "The Effect of Adding Exenatide to a Thiazolidinedione in Suboptimally Controlled Type 2 Diabetes.

Amylin Pharmaceuticals Reports First Quarter Financial Results  -  Apr 16, 2007
PR-Inside.com (Pressemitteilung),Net product sales of $162.0 million for the first quarter include $146.5 million for BYETTA(R) (exenatide) injection and $15.5 million for SYMLIN(R)

Amylin Pharmaceuticals Reports First Quarter Financial Results  -  Apr 16, 2007
PR Newswire (press release),Exenatide LAR and our other pipeline programs are on track, positioning us well for future sustainable growth." Net product sales of $162.0 million for the

Adding new diabetes drug may aid glycemic control  -  Apr 4, 2007
Scientific AmericanThe addition of exenatide to thiazolidinediones (TZDs), drugs such as rosiglitazone or pioglitazone, that increase cell response to insulin,

Diabetes and Incretin-based Therapy  -  Apr 4, 2007
Journal of Clinical Endocrinology and Metabolism,An incretin mimetic, such as exenatide, copies (or mimics) the action of GLP-1 that is produced by your body. The difference between the two is that

Amylin Pharma Reports Narrower Loss In Q1 On Higher Revenue - Update  -  Apr 16, 2007
Trading Markets,The company said it completed enrollment in the ongoing long-term comparator study of once- weekly exenatide long-acting release, or LAR, in patients with

Medialink Features: Delta Burke to Americans - Let's Talk About ...  -  Apr 18, 2007
PharmaLive.com (press release),...including taking the right medication, such as BYETTA(r) (exenatide) injection, the first in a new class of drugs to help manage type 2 diabetes.

Byetta Approved for Use with TZDs  -  Apr 13, 2007
Diabetes Health (press release),In a clinical trial, 62 percent of patients who added Byetta (exenatide) to their TZD regimen achieved an A1c of 7 percent or less, compared to 16 percent

What Percentage of Diabetes Patients Would Prefer to Use an ...  -  Apr 5, 2007
PharmaLive.com (press release),Are physicians likely to prescribe or recommend Byetta (Exenatide) to diabetes patients in the next 12 months? - What percentage of type 2 diabetes patients

Amylin Pharmaceuticals "sell"  -  Mar 28, 2007
newratings.com...were short of those achieved by Amylin Pharmaceuticals’ Byetta/exenatide. ConjuChem aims to commence a larger 12-week study in 2H07, the analysts say.

Insulin Analogs or Premixed Insulin Analogs in Combination With ...  -  Apr 17, 2007
Medscape (subscription)Exenatide: effect of injection time on postprandial glucose in patients with type 2 diabetes. Diabet Med. 2006;23:240-245. Abstract. Heine RJ, Van Gaal LF,

The Incretin Saga: Mimetics, Enhancers, and Inhibitors  -  Apr 20, 2007
Diabetes Health (press release),Byetta (exenatide) is an incretin mimetic. It is taken twice daily by injection. So there you have the story, and now you’ll have a much easier time keeping

AACE: Surgery Proposed for Intractable Type 2 Diabetes  -  Apr 12, 2007
MedPage Today,...and it's almost like taking exenatide [Byetta]: you have high levels of GLP-1, you get increased beta-cell mass, so you correct that beta-cell defect

The link between obesity and diabetes: Are you at risk?  -  Apr 11, 2007
Petaluma Argus-Courier,...about new antidiabetic drugs available which also suppress appetite, such as pramlintide, exenatide and rimonabant (still pending FDA approval).

Amylin Pharmaceuticals to Webcast First Quarter Results  -  Apr 10, 2007
PharmaLive.com (press release),Amylin has developed and gained approval for two first- in-class medicines for diabetes, SYMLIN(R) (pramlintide acetate) injection and BYETTA(R) (exenatide)

Delta Burke Talks About Diabetes  -  Apr 4, 2007
SolancoNews.com,...including taking the right medication, such as BYETTA® (exenatide) injection, the first in a new class of drugs to help manage type 2 diabetes.

Annals of Internal Medicine tip sheet for April 3, 2007  -  Apr 2, 2007
EurekAlert (press release),A study of 233 people with type 2 diabetes not well controlled with thiazolidinediones (with or without metformin) found that the addition of exenatide

Amylin could make major investment in West Chester  -  Mar 28, 2007
Bizjournals.com,The company will make a long-acting release formulation of exenatide, a compound in development for the management of Type 2 diabetes, at the facility.

Billion dollar babies—biotech drugs as blockbusters  -  Apr 3, 2007
Nature.com (subscription),...population that's in the wings is San Diego–based Amylin Pharmaceuticals' once-weekly injectable version of Byetta (exenatide) for type II diabetes.

$2.5 MILLION AWARDED TO HIGH TECHNOLOGY COMPANIES Third Frontier ...  -  Mar 28, 2007
ODOD (press release),Amylin has developed and gained approval for two first-in-class medicines to treat diabetes, BYETTA® (exenatide) injection and SYMLIN® (pramlintide acetate)

Lilly Reports Strong First-Quarter Results; Raises Full-Year Sales ...  -  Apr 16, 2007
Earthtimes.orgActos(R) (pioglitazone hydrochloride, Takeda) Alimta(R) (pemetrexed, Lilly) Arxxant(TM) (ruboxistaurin mesylate, Lilly) Byetta(R) (exenatide injection,

Delta Burke to Americans: Let's Talk about Managing Diabetes  -  Mar 14, 2007
PR Newswire (press release),Virginia Valentine, a certified diabetes educator, will be available to talk one-on-one with attendees about the disease and BYETTA(R) (exenatide) injection

Amylin Pharmaceuticals to Present at Lehman Brothers Global ...  -  Mar 13, 2007
PR Newswire (press release),Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN(R) (pramlintide acetate) injection and BYETTA(R) (exenatide)

Delta Burke to Americans: Let's Talk about Managing Diabetes  -  Mar 22, 2007
Drug Newswire (press release),For more information about the campaign, type 2 diabetes and BYETTA(R) (exenatide) injection, and for a list of campaign events and dates, go to www.

Alkermes Announces Senior Management Succession Plan  -  Mar 5, 2007
PharmaLive.com (press release),RISPERDAL CONSTA and VIVITROL, a strong program in diabetes with late-stage clinical studies ongoing for exenatide LAR and AIR Insulin, and a pipeline

New Storage Instructions Approved For BYETTA®  -  Feb 25, 2007
Medical News Today (press release),...(1) Kolterman, O, Buse J, Fineman M, Gaines E, Heintz S, Bicsak T, Taylor K, Kim D, Aisporna M, Wang Y, Baron A. Synthetic exendin-4 (exenatide)

Zacks Analyst Interview Highlights: Alkermes, Johnson & Johnson ...  -  Mar 13, 2007
Business Wire (press release),Alkermes is also collaborating with Eli Lilly (NYSE: LLY) for inhalational insulin and Exenatide LAR for diabetes. Our target price for Alkermes is $20.

Incretin mimetics vie for slice of type 2 diabetes market  -  Mar 1, 2007
Nature.com (subscription),Indeed, inspired by the success of San Diego-based biotech Amylin with Byetta (exenatide), the only approved biotech diabetes drug (excluding insulin

New storage instructions approved for Byetta  -  Feb 25, 2007
SpiritIndia,...announced that the US Food and Drug Administration (FDA) has approved more convenient patient storage instructions for BYETTA® (exenatide) injection.

New Storage Instructions Approved For BYETTA®  -  25 Feb 2007
Medical News Today (press release),...(1) Kolterman, O, Buse J, Fineman M, Gaines E, Heintz S, Bicsak T, Taylor K, Kim D, Aisporna M, Wang Y, Baron A. Synthetic exendin-4 (exenatide)

Revised Byetta Storage Instructions Approved  -  Feb 22, 2007
Facts and Comparisons,The FDA has approved new patient storage instructions for Amylin Pharmaceuticals and Lilly’s Byetta (exenatide) injection. The pens can now be stored at a

Market Report -- In Play (AMLN)  -  Feb 20, 2007
MSN Money...for BYETTA The co and Eli Lilly (LLY) announces the FDA has approved more convenient patient storage instructions for BYETTA (exenatide) injection.

Amylin Pharmaceuticals Reports 2006 Financial Results  -  Feb 1, 2007
Drug Newswire (press release),Net product sales of $150.6 million for the quarter include sales of $137.0 million for BYETTA(R) (exenatide) injection and $13.6 million for SYMLIN(R)

Amylin Pharmaceuticals Reports 2006 Financial Results  -  Jan 30, 2007
PR Newswire (press release),Quarter ended December 31, 2006 Net product sales of $150.6 million for the quarter include sales of $137.0 million for BYETTA(R) (exenatide) injection and

Dosing Convenience is Mandatory to Keep Pace in the Pipeline Race ...  -  Feb 6, 2007
PR.com (press release),Lilly’s and Amylin’s first-in-class, but twice-daily product exenatide posted 2006 sales of US$ 430.2 mln in the first full market year and gained FDA

New Storage Instructions Approved for Byetta  -  Feb 21, 2007
PharmaLive.com (press release),...(1) Kolterman, O, Buse J, Fineman M, Gaines E, Heintz S, Bicsak T, Taylor K, Kim D, Aisporna M, Wang Y, Baron A. Synthetic exendin-4 (exenatide)

Amylin Pharmaceuticals to Present at Merrill Lynch Global ...  -  Feb 1, 2007
Drug Newswire (press release),Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN(R) (pramlintide acetate) injection and BYETTA(R) (exenatide)

Amylin Pharmaceuticals to Present at Merrill Lynch Global ...  -  Jan 31, 2007
Yahoo! News (press release)Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN® (pramlintide acetate) injection and BYETTA® (exenatide)

Lilly Announces Changes For Storage of Diabetes Medication  -  Feb 21, 2007
Inside INdiana Business (press release),...today that the US Food and Drug Administration (FDA) has approved more convenient patient storage instructions for BYETTA® (exenatide) injection.

Pfizer pfurther diabetes research  -  Feb 2, 2007
LabTechnologist.com,One example is Byetta (exenatide), which was developed by Eli Lilly and Amylin. However, Byetta still needs to be administered via injection.

Cymbalta is bright spot as charges batter Lilly net income  -  Feb 1, 2007
Pharma Times (subscription),Lilly's diabetes care franchise, including its insulin range and Byetta (exenatide), grew 4% to $781.7 million, with Humalog (insulin lispro) driving the

Lilly Announces 2006 Adjusted EPS of $3.18 Excluding Charges and ...  -  Jan 31, 2007
Earthtimes.orgActos(R) (pioglitazone hydrochloride, Takeda), Takeda Alimta(R) (pemetrexed, Lilly) Byetta(R) (exenatide injection, Amylin Pharmaceuticals) Cialis(R)

Lilly Announces 2006 Adjusted EPS of $3.18 Excluding Charges and ...  -  Jan 31, 2007
Yahoo! News (press release)Actos® (pioglitazone hydrochloride, Takeda), Takeda Alimta® (pemetrexed, Lilly) Byetta® (exenatide injection, Amylin Pharmaceuticals) Cialis® (tadalafil,

New Diabetes Medicine from Gila Monster Saliva Causes Excitement  -  18 Jan 2007
National Ledger,Bronx VA Medical Center endocrinologist John Eng discovered the active ingredient in Byetta, called exenatide, in the early 1990s while looking at a sample

FDA Approves BYETTA(R) (exenatide) Injection for Expanded ...  -  Jan 4, 2007
PipelineReview.com (press release),..."The combination of exenatide with metformin, sulfonylureas, or TZDs not only expands our options to achieve optimal glycemic control, but does so with

Diabetes Drug Byetta Approved for Use By Diabetics Taking Actos or ...  -  Jan 3, 2007
Diabetes Drug Report,Diabetes drug Byetta (exenatide), an injected drug used by type 2 diabetics who were not able to achieve adequate blood sugar control on the commonly

(PRN) - Ness Technologies Announces Sale of its Ownership Interest ...  -  Jan 3, 2007
Bolsamania.com,...(PRN) - FDA Approves BYETTA(R) (exenatide) Injection for Expanded Combination Use ... [+]. (PRN) - FoxHollow Technologies to Participate in 25th Annual

Medialink Features: Controlling Blood Sugar Key to Diabetes Management  -  Jan 17, 2007
PR Newswire (press release),With this in mind, Yarnall's doctor recommended BYETTA(R) (exenatide) injection, a type 2 diabetes treatment that helps regulate blood sugar when taken in

Amylin Pharmaceuticals to Present at JPMorgan Healthcare Conference  -  Jan 3, 2007
PharmaLive.com (press release),Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN(R) (pramlintide acetate) injection and BYETTA(R) (exenatide)

Byetta Approved for Expanded Combination Use  -  Jan 3, 2007
Facts and Comparisons,The FDA has approved Amylin Pharmaceuticals’ and Eli Lilly and Company’s Byetta (exenatide) injection as add-on therapy to improve glycemic control in

Amylin Pharmaceuticals to Present at JPMorgan Healthcare Conference  -  Jan 2, 2007
Yahoo! News (press release)Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN® (pramlintide acetate) injection and BYETTA® (exenatide)

Court backs Lilly's patent on Zyprexa until 2011  -  Jan 1, 2007
Pharma Times (subscription),Amylin Pharmaceuticals have been celebrating the news that the US Food and Drug Administration has approved the diabetes drug Byetta (exenatide) as an

Tuesday's Health Winners & Losers  -  Dec 26, 2006
TheStreet.comByetta (exenatide) injection is approved as an add-on therapy to improve blood sugar control in people with type 2 diabetes who have not achieved adequate

(PRN) - American Stock Exchange Lists Morgan Stanley's 7.5 Percent ...  -  Dec 22, 2006
Bolsamania.com,Decatur, and Quincy, Illinois to Chicago Midway ... [+]. (PRN) - FDA Approves BYETTA(R) (exenatide) Injection for Expanded Combination Use ... [+]

(PRN) - American Stock Exchange Lists Morgan Stanley's 7.5 Percent ...  -  Dec 22, 2006
Bolsamania.com,...(PRN) - FDA Approves BYETTA(R) (exenatide) Injection for Expanded Combination Use ... [+]. (PRN) - Irwin Financial Corporation Announces Issuance of $15

Pharma Sector: Few Newsmakers Of The Week - Bristol-Myers, Glaxo ...  -  Dec 23, 2006
Trading Markets,Byetta also known as Exenatide, indicated for the treatment of type 2 diabetes was launched in the US in June 2005. In the United States, Lilly co-markets

Tuesday's Health Winners & Losers  -  26 Dec 2006
TheStreet.comByetta (exenatide) injection is approved as an add-on therapy to improve blood sugar control in people with type 2 diabetes who have not achieved adequate

FDA Approves BYETTA(R) (exenatide) Injection for Expanded ...  -  Dec 22, 2006
PR Newswire (press release),..."The combination of exenatide with metformin, sulfonylureas, or TZDs not only expands our options to achieve optimal glycemic control, but does so with

International Approvals: Byetta and Noxafil  -  Nov 28, 2006
Medscape (subscription)November 28, 2006 — The European Commission has approved exenatide injection as adjunctive therapy to improve glycemic control in diabetic patients who are

Partnerships between life sciences firms, biotech companies ...  -  Dec 8, 2006
San Diego Daily Transcript (subscription),In November, the two companies announced the European Commission approved the use of exenatide for the treatment of type 2 diabetes.

(PRN) - American Stock Exchange Lists Morgan Stanley's 7.5 Percent ...  -  Dec 22, 2006
Bolsamania.com,Decatur, and Quincy, Illinois to Chicago Midway ... [+]. (PRN) - FDA Approves BYETTA(R) (exenatide) Injection for Expanded Combination Use ... [+]

(PRN) - American Stock Exchange Lists Morgan Stanley's 7.5 Percent ...  -  Dec 22, 2006
Bolsamania.com,...(PRN) - FDA Approves BYETTA(R) (exenatide) Injection for Expanded Combination Use ... [+]. (PRN) - Irwin Financial Corporation Announces Issuance of $15

Pharma Sector: Few Newsmakers Of The Week - Bristol-Myers, Glaxo ...  -  Dec 23, 2006
Trading Markets,Byetta also known as Exenatide, indicated for the treatment of type 2 diabetes was launched in the US in June 2005. In the United States, Lilly co-markets

Controlling Blood Sugar Key to Diabetes Management  -  Dec 12, 2006
Toronto Daily News,With this in mind, Yarnall's doctor recommended BYETTA (exenatide) injection, a type 2 diabetes treatment that helps regulate blood sugar when taken in

Lilly opts for caution with 2007 earnings estimates  -  Dec 8, 2006
Pharma Times (subscription),Other top-sellers should be the antidepressant Cymbalta (duloxetine), the diabetes drug Byetta (exenatide), cancer treatment Alimta (pemextred) and Forteo

Medical Edge: Care pays off for diabetics  -  Dec 2, 2006
Bryan College Station Eagle,A new drug called exenatide (brand-name Byetta) is a natural hormone - glucagon-like peptide-1, or GLP-1 - that enhances insulin production in the pancreas.

Lilly Delivers Promising Update to Wall Street on Strategic ...  -  Dec 7, 2006
Yahoo! News (press release)AIR® (Alkermes, Inc.) Alimta® (pemetrexed disodium, Lilly) Byetta® (exenatide injection, Amylin Pharmaceuticals) Cialis® (tadalafil, ICOS), Lilly ICOS LLC

Lilly Delivers Promising Update to Wall Street on Strategic ...  -  Dec 7, 2006
PR Newswire (press release),AIR(R) (Alkermes, Inc.) Alimta(R) (pemetrexed disodium, Lilly) Byetta(R) (exenatide injection, Amylin Pharmaceuticals) Cialis(R) (tadalafil, ICOS),

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional